Cargando…
Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial
INTRODUCTION: This randomized, double-blind trial aimed to test effect of a Chinese herbal medicine, Qinggongshoutao (QGST) pill, on the cognition and progression of amnestic mild cognitive impairment (aMCI). METHODS: Patients with aMCI were randomly assigned to receive QGST, Ginkgo biloba extract,...
Autores principales: | Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Ni, Jingnian, Fang, Zhiyong, Gao, Jinyu, Wang, Heng, Yao, Hongjun, Zhang, Jintao, Li, Juntao, Min, Min, Su, Likai, Sun, Xiuqiao, Wang, Baoai, Wang, Baoshen, Yang, Faming, Zou, Yong, Hu, Yueqiang, Lin, Yaming, Xu, Guangyin, Li, Kang, Li, Lei, Zhen, Hui, Xu, Jinyan, Chen, Keji, Wang, Yongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732732/ https://www.ncbi.nlm.nih.gov/pubmed/31517031 http://dx.doi.org/10.1016/j.trci.2019.03.001 |
Ejemplares similares
-
Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial
por: Tian, Jinzhou, et al.
Publicado: (2017) -
The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2016) -
Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice
por: Shi, Jing, et al.
Publicado: (2016) -
Retraction Note: Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice
por: Shi, Jing, et al.
Publicado: (2021) -
Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial
por: Tian, Jinzhou, et al.
Publicado: (2018)